Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia

Outcomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia

To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with bronchopulmonary dysplasia

The purpose of this study is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cells in 10 patients with bronchopulmonary dysplasia at Vinmec International Hospital, Hanoi, Vietnam

Inclusion Criteria:

• The patient is diagnosis Bronchopulmonary Dysplasia (premature and depends on oxygen until 28 days old
• Gender: either sex
• Year old < 6 months
• Weight ≥ 2 kg
• Agree to participate in the study.

Exclusion Criteria:

• Severe congenital malformation.
• Other severe conditions (active pulmonary bleeding, evidence of active infections).